Benign prostatic hyperplasia (BPH), also called prostate gland enlargements, is a condition that affects mostly middle-aged men. The most common symptoms are difficulty in fully emptying the bladder, a frequent and urgent need to urinate, and nocturia (a condition that causes the sufferer to wake up during the night to urinate.
Although usually not a serious threat to health, it can negatively affect the patient’s quality life. Left untreated, it could also lead to complications such as urinary tract infection (UTI) or acute urinary retention (the sudden inability to pass any urine).
Rezūm technology uses heat from radiofrequency-generated water vapour to ablate prostate tissue. The therapy is a minimally invasive treatment for an enlarged prostate that uses controlled doses of hot steam to directly evaporate and reduce portions of the swollen prostate that are causing obstruction of the urethra.
Rezūm has undergone rigorous studies and is recommended by the Canadian Urological Association as a minimally invasive BPH symptom reduction method for men interested in preserving erectile and ejaculatory function. It was also approved by the US FDA in 2015 for the treatment of the enlarged prostate.
SanoMed is the first clinic to offer Rezūm in Quebec and Eastern Canada.